Skip to main content
EKF DIAGNOSTICS HOLDINGS PLC logo

EKF DIAGNOSTICS HOLDINGS PLC — Investor Relations & Filings

Ticker · EKF ISIN · GB0031509804 LEI · 213800DXTF3EAUK1AR05 IL Manufacturing
Open in API
Filings indexed 504 across all filing types
Latest filing 2023-03-28 Earnings Release
Country GB United Kingdom
Listing IL EKF

About EKF DIAGNOSTICS HOLDINGS PLC

https://www.ekfdiagnostics.com/

EKF Diagnostics Holdings plc is a global in-vitro diagnostics (IVD) and biotechnology company that develops, manufactures, and distributes medical technologies. The company provides solutions for both point-of-care (POC) and central laboratory settings. Its product portfolio includes a range of analyzers, reagents, and tests for critical parameters such as hemoglobin, HbA1c, glucose, and lactate, which are used for the early detection, diagnosis, and monitoring of various conditions. EKF also offers products for life sciences applications, supporting therapeutic development and high-throughput analysis. The company is focused on delivering reliable, accurate, and cost-effective diagnostic tools to empower healthcare professionals and enhance patient outcomes.

Recent filings

Filing Released Lang Actions
Final Results
Earnings Release Classification · 1% confidence The document explicitly states it announces the "Final results for the year ended 31 December 2022." It contains detailed financial highlights (Revenues, Gross profit, Adjusted EBITDA, Loss before tax) and operational highlights for the full year. This structure is characteristic of a comprehensive annual financial report summary. Although it is presented via RNS (Regulatory News Service), the content itself is the full annual results, which aligns best with the Annual Report (10-K) definition, or potentially an Interim/Quarterly Report (IR) if it were for a shorter period. Since it covers the full year (ended 31 December 2022), it is the annual result announcement. Given the options, '10-K' is the US equivalent for a full annual report, but in the context of UK/AIM filings where this RNS originates, the content is the definitive annual results. Since the definition for '10-K' is 'Official yearly report covering company activity and full financial performance,' and this document presents the final yearly performance, it is the most appropriate classification, even if it's an RNS announcement *of* those results. However, the document is clearly a summary/release of the final results, not the full statutory 10-K filing itself. It strongly resembles an Earnings Release (ER) but covers the full year, not just a quarter. Given the depth of financial data and the mention of the full year, it is more substantial than a typical ER. Since it is the final, comprehensive annual result announcement, and not just a brief announcement linking to the report (which would be RPA/RNS), I will classify it as the closest match to a full annual report summary, which is 10-K, or potentially ER if we strictly follow the 'Menu vs Meal' rule for RNS announcements. Since the document is very long (76k chars) and contains detailed financial tables and management commentary on the full year, it is more than just a brief announcement. It is the official release of the annual results. In the provided schema, '10-K' is for the 'Official yearly report'. This is the announcement of those results. If the document were shorter and just pointed to the report, it would be RPA. Because it contains the core results, it is closest to ER (Earnings Release) but for the full year. Given the options, and the fact that it is the *final* results for the *year*, it functions as the primary annual results disclosure. I will select ER as it is the standard classification for the initial release of financial results, even if annual, unless it is the full statutory filing. Since it is an RNS announcement, ER is often used for preliminary results releases. I will lean towards ER as it is the initial release of the annual figures via RNS, rather than the full statutory 10-K document itself. However, the presence of the Investor Presentation link and the comprehensive nature suggests it's the primary results disclosure. Let's re-evaluate: It is the 'Final results' announcement. This is typically classified as an Earnings Release (ER). FY 2022
2023-03-28 English
Disposal of ADL Health
Regulatory Filings Classification · 1% confidence The document is an official announcement disseminated via RNS (RNS Number : 9296T) from EKF Diagnostics Holdings PLC, dated March 23, 2023. It details the 'Disposal of ADL Health,' which is a significant corporate transaction (sale of a subsidiary). This type of announcement, which reports on a specific corporate event (like a disposal, management change, or major transaction) and is distributed through regulatory news services like RNS, fits best under the general 'Regulatory Filings' category, as there is no specific code for M&A/Disposal announcements other than TAR (Merger/Takeover Bids), which this is not strictly, or a specific corporate action code. Since it is a formal, non-financial results announcement distributed via the LSE's RNS system, RNS is the most appropriate classification, serving as the general regulatory announcement fallback.
2023-03-23 English
Notice of Results and Investor Presentation
Report Publication Announcement Classification · 1% confidence The document is an official announcement from EKF Diagnostics Holdings PLC, identified by the RNS Number (3991R) and the mention of RNS, the news service of the London Stock Exchange. The title is "Notice of Preliminary Results and Investor Presentation." This document explicitly states *when* the preliminary results will be announced (March 28, 2023) and details an accompanying investor presentation, but it does not contain the actual preliminary results or the full annual report. According to Rule 2, when a document announces the publication of a report (like preliminary results) and provides details about an associated presentation, it fits the definition of a Report Publication Announcement (RPA). It is not the full report (10-K or IR), nor is it the presentation itself (IP), but the notice of their release/event.
2023-03-01 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is clearly identified by the header 'RNS Number : 6111Q' and contains the standard disclaimer about RNS being the news service of the London Stock Exchange, approved by the FCA. The content itself is a 'TR-1: Standard form for notification of major holdings,' detailing an acquisition of voting rights by Liontrust Investment Partners LLP, crossing the 10% threshold. This type of mandatory disclosure regarding significant changes in share ownership falls directly under the definition of 'Major Shareholding Notification' (MRQ). Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2023-02-21 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is explicitly titled 'TR-1: Standard form for notification of major holdings' and contains an 'RNS Number'. It details an 'acquisition or disposal of voting rights' by Liontrust Investment Partners LLP, crossing a threshold (from 10.000% to 10.064%). This type of mandatory disclosure regarding changes in significant share ownership is specifically covered by the Major Shareholding Notification category. Although it is distributed via RNS, the specific content points directly to the Major Shareholding Notification definition.
2023-02-10 English
Trading update
Earnings Release Classification · 1% confidence The document is an announcement released via RNS (Regulatory News Service) on February 6, 2023. It provides an 'unaudited trading update for the year ended 31 December 2022 (FY 2022)' including summary expected results, divisional commentary, and an outlook. Crucially, it states that further guidance will be provided at the release of full-year results in late March 2023. This structure—a preliminary update on performance before the final audited report—is characteristic of an Earnings Release (ER). It contains key financial highlights and operational updates but is not the comprehensive Annual Report (10-K) or the detailed Management Discussion & Analysis (MDA). It also announces immediate changes to the CEO role, which is secondary to the primary financial update purpose. Since it is an initial announcement of period results, ER is the most appropriate classification. FY 2022
2023-02-06 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.